Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
In this study, memantine will be tested in a new indication: in the treatment of subjective
memory, concentration, or attention problems (subjective cognitive impairment) in the absence
of dementia.